Free Access
Vet. Res.
Volume 40, Number 1, January-February 2009
Number of page(s) 12
Published online 28 October 2008
How to cite this article Vet. Res. (2009) 40:08
References of  Vet. Res. (2009) 40:08
  1. Arnold M.E., Ryan J.B.M., Konold T., Simmons M.M., Spencer Y.I., Wear A., et al., Estimating the temporal relationship between PrP$^{\rm Sc}$ detection and incubation period in experimental bovine spongiform encephalopathy (BSE) of cattle, J. Gen. Virol. (2007) 88:3198–3208 [CrossRef] [PubMed].
  2. Beekes M., Baldauf E., Diringer H., Sequential appearance and accumulation of pathognomonic markers in the central nervous system of hamsters orally infected with scrapie, J. Gen. Virol. (1996) 77:1925–1934 [CrossRef] [PubMed].
  3. Buschmann A., Groschup M.H., Highly bovine spongiform encephalopathy-sensitive transgenic mice confirm the essential restriction of infectivity to the nervous system in clinically diseased cattle, J. Infect. Dis. (2005) 192:934–942 [CrossRef] [PubMed].
  4. Comer P.J., Huntly P.J., TSE risk assessments: a decision support tool, Stat. Methods Med. Res. (2003) 12:279–291 [CrossRef] [PubMed] [MathSciNet].
  5. Comer P.J., Huntly P.J., Exposure of the human population to BSE infectivity over the course of the BSE epidemic in Great Britain and the impact of changes to the Over Thirty Month Rule, J. Risk Res. (2004) 7:523–543 [CrossRef].
  6. Cooper J.D., Bird S.M., UK dietary exposure to BSE in head meat: by birth cohort and gender, J. Cancer Epidemiol. Prev. (2002) 7:71–83 [CrossRef] [PubMed].
  7. Czub M., Braig H.R., Diringer H., Pathogenesis of scrapie: Study of the temporal development of clinical symptoms, of infectivity titres and scrapie-associated fibrils in brains of hamsters infected intraperitoneally, J. Gen. Virol. (1986) 67:2005–2009 [CrossRef] [PubMed].
  8. De Koeijer A.A., Heesterbeek J.A.P., Schreuder B.E.C., Oberthur R.C.,Wilesmith J.W., van Roermund H., de Jong M.C.M., Quantifying BSE control by calculating the basic reproduction ratio R0 for the infection among cattle, J. Math. Biol. (2004) 48:1–22 [CrossRef] [PubMed] [MathSciNet].
  9. Dickinson A.G., Meikle M.H., Fraser H., Identifi- cation of a gene which controls the incubation period of some strains of scrapie agent in mice, J. Comp. Pathol. (1968) 78:293–299 [CrossRef] [PubMed].
  10. Dickinson A.G., Meikle V.M., Fraser H.J., Genetical control of the concentration of ME7 scrapie agent in the brain of mice, J. Comp. Pathol. (1969) 79:15–22 [CrossRef] [PubMed].
  11. Ducrot C., Arnold M.E., de Koeijer A.A., Heim D., Calavas D., Review on the epidemiology and dynamics of BSE, Vet. Res. (2008) 39:15 [PubMed] [EDP Sciences].
  12. EFSA, Quantitative assessment of the residual risk in bovine derived by-products, The EFSA Journal (2005) 307:1–135.
  13. Espinosa J.C., Morales M., Castilla J., Rogers M., Torres J.M., Progression of prion infectivity in asymptomatic cattle after oral bovine spongiform encephalopathy challenge, J. Gen. Virol. (2007) 88:1379–1383 [CrossRef] [PubMed].
  14. Ferguson N.M., Donnelly C.A., Woolhouse M.E.J., Anderson R.M., The epidemiology of BSE in cattle herds in Great Britain II: model construction and analysis of transmission dynamics, Phil. Trans. R. Soc. Lond. B Biol. Sci. (1997) 352:803–838 [CrossRef].
  15. Ferguson N.M., Donnelly C.A., Woolhouse M.E.J., Anderson R.M., Estimation of the basic reproduction number of BSE: the intensity of transmission in British cattle, Proc. Biol. Sci. (1999) 266:23–32 [CrossRef] [PubMed].
  16. Ferguson N.M., Donnelly C.A., Assessment of the risk posed by bovine spongiform encephalopathy in cattle in Great Britain and the impact of potential changes to current control measures, Proc. Biol. Sci. (2003) 270:1579–1584 [CrossRef] [PubMed].
  17. Fraser H., Bruce M.E., Chree A., Mcconnell I., Wells G.A.H. Transmission of bovine spongiform encephalopathy and scrapie to mice, J. Gen. Virol. (1992) 73:1891–1897 [CrossRef] [PubMed].
  18. Ghani A.C., Ferguson N.M., Donnelly C.A., Hagenaars T.J., Anderson R.M., Epidemiological determinants of the pattern and magnitude of the vCJD epidemic in Great Britain, Proc. Biol. Sci. (1998) 265:2443–2452 [CrossRef] [PubMed].
  19. Ghani A.C., Donnelly C.A., Ferguson N.M., Anderson R.M., Assessment of the prevalence of vCJD through testing tonsils and appendices for abnormal prion protein, Proc. Biol. Sci. (2000) 267:23–29 [CrossRef] [PubMed].
  20. Hagenaars T.J., Ferguson N.M., Donnelly C.A., Ghani A.C., Anderson R.M., Feed-borne transmission and case clustering of BSE, Proc. R. Soc. Lond. B. (2000) 267:205–215 [CrossRef].
  21. Hoffmann C., Ziegler U., Buschmann A., Weber A., Kupfer L., Oelschlegel A., et al., Prions spread via the autonomic nervous system from the gut to the central nervous system in cattle incubating bovine spongiform encephalopathy, J. Gen. Virol. (2007) 88:1048–1055 [CrossRef] [PubMed].
  22. Karber G., Beitrag zur kollectiven Behandung Pharmakologische Reihen versuche, Arch. Exp. Pathol. Pharmacol. (1931) 162:480–483 [CrossRef].
  23. Kimberlin R.H., Walker C.A., Pathogenesis of experimental scrapie, In: Bock G., Marsh J. (Eds.), Novel Infectious Agents and the Central Nervous System, CIBA Foundation Symposium 135, Chichester, Wiley, 1988, pp. 37–62.
  24. Kimberlin R.H., Bovine spongiform encephalopathy and public health: some problems and solutions in assessing the risk 1996, In: Court L., Dodet B. (Eds.), 3rd International Symposium on Transmissible Subacute Spongiform Encephalopathies: Prion Diseases, Paris, Amsterdam, Elsevier, 1996, pp. 487–502.
  25. Masujin K., Matthews D., Wells G.A.H., Mohri S., Yokoyama T., Prions in the peripheral nerves of bovine spongiform encephalopathy-affected cattle, J. Gen. Virol. (2007) 88:1850–1858 [CrossRef] [PubMed].
  26. Prusiner S.B., Cochran S.P., Groth D.F., Downey D.E., Bowman K.A., Martinez H.M., Measurement of the scrapie agent using an incubation time interval assay, Ann. Neurol. (1982) 11:353–358 [CrossRef] [PubMed].
  27. Robinson M.M., Cheevers W.P., Burger D., Gorham J.R., Organ-specific modification of the doseresponse relationship of scrapie infectivity, J. Infect. Dis. (1990) 161:783–786 [PubMed].
  28. Taylor D.M., Fraser H., McConnell I., Brown D.A., Brown K.L., Lamza K.A., Smith G.R., Decontamination studies with the agents of bovine spongiform encephalopathy and scrapie, Arch. Virol. (1994) 139:313–326 [CrossRef] [PubMed].
  29. Terry L.A.,Marsh S., Ryder S.J., Hawkins S.A.C., Wells G.A.H., Spencer Y.I., Detection of diseasespecific PrP in Peyer's patches of the distal ileum of cattle orally exposed to the BSE agent, Vet. Rec. (2003) 152:387–392 [PubMed].
  30. Wells G.A.H., Dawson M., Hawkins S.A.C., Green R.B., Dexter I., Francis M.E., et al., Infectivity in the ileum of cattle challenged orally with bovine spongiform encephalopathy, Vet. Rec. (1994) 135:40–41 [PubMed].
  31. Wells G.A.H., Dawson M., Hawkins S.A.C., Austin A.R., Green R.B., Dexter I., et al., Preliminary Observations on the pathogenesis of experimental bovine spongiform encephalopathy, In: Gibbs C.J. (Ed.), Bovine spongiform encephalopathy: The BSE Dilemma, New York, Serona Symposia, Norwell, USA Springer-Verlag, 1996, pp. 28–44.
  32. Wells G.A.H., Hawkins S.A.C., Green R.B., Austin A.R., Dexter I., Spencer Y.I., et al., Preliminary observations on the pathogenesis of experimental bovine spongiform encephalopathy (BSE) – An update, Vet. Rec. (1998) 142:103–106 [PubMed].
  33. Wells G.A.H., Hawkins S.A.C., Green R.B., Spencer Y.I., Dexter I., Dawson M., Limited detection of sternal bone marrow infectivity in the clinical phase of experimental bovine spongiform encephalopathy (BSE), Vet. Rec. (1999) 144:292–294 [PubMed].
  34. Wells G.A.H., Spiropoulos J., Hawkins S.A.C., Ryder S.J., Pathogenesis of experimental bovine spongiform encephalopathy (BSE): pre-clinical infectivity in tonsil and observations on lingual tonsil in slaughtered cattle, Vet. Rec. (2005) 156:401–407 [PubMed].
  35. Wells G.A.H., Konold T., Arnold M.E., Austin A.R., Hawkins S.A.C., Stack M., et al., Bovine spongiform encephalopathy: the effect of oral exposure dose on attack rate and incubation period in cattle, J. Gen. Virol. (2007) 88:1363–1373 [CrossRef] [PubMed].